Summary results and recommendations from the age-related eye disease study

Archives of Ophthalmology

Volumn 127, Issue 12, 2009, Pages 1678-1679

  Chew, Emily Y ^a   Lindblad, Anne S ^b   Clemons, Traci ^b  

^a NATIONAL EYE INSTITUTE   (United States)

^b EMMES CORPORATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; ZINC; VITAMIN;

AGING; ARTICLE; CATARACT; CLINICAL TRIAL; DRUG EFFECT; DRUG MEGADOSE; DRUSEN; EYE DISEASE; EYE FUNDUS; HIGH RISK POPULATION; HUMAN; LASER COAGULATION; MAJOR CLINICAL STUDY; PIGMENT EPITHELIUM; PRIORITY JOURNAL; RETINA DETACHMENT; RETINA MACULA AGE RELATED DEGENERATION; RETINA MACULA DEGENERATION; RISK REDUCTION; SUBRETINAL NEOVASCULARIZATION; TREATMENT OUTCOME; VISUAL ACUITY; VISUAL IMPAIRMENT; DIET SUPPLEMENTATION; DRUG COMBINATION; META ANALYSIS; PRACTICE GUIDELINE;

ANTIOXIDANTS; CATARACT; CLINICAL TRIALS AS TOPIC; DIETARY SUPPLEMENTS; DRUG THERAPY, COMBINATION; HUMANS; MACULAR DEGENERATION; PRACTICE GUIDELINES AS TOPIC; VITAMINS; ZINC;

EID: 73349142716     PISSN: 00039950     EISSN: 15383601     Source Type: Journal    
DOI: 10.1001/archophthalmol.2009.312     Document Type: Article

References (11)

1. Congdon N, O'Colmain B, Klaver CC, et al; Eye Diseases Prevalence Research Group. Causes and prevalence of visual impairment among adults in the United States. Arch Ophthalmol. 2004;122(4):477-485.
2. Friedman DS, O'Colmain BJ, Muñoz B, et al; Eye Disease Prevalence Research Group. Prevalence of age-related macular degeneration in the United States. Arch Ophthalmol. 2004;122(4):564-572.
3. Age-Related Eye Disease Study Research Group. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS Report No. 8. Arch Ophthalmol. 2001;119(10):1417-1436.
4. Age-Related Eye Disease Study Research Group. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E and beta carotene for age-related cataract and vision loss: AREDS Report No. 9. Arch Ophthalmol. 2001;119(10):1439-1452.
5. Omenn GS, Goodman GE, Thornquist MD, et al. Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease. N Engl J Med. 1996;334(18):1150-1155.
6. Alpha-Tocopherol, Beta Carotene Cancer Prevention Study group. The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. N Engl J Med. 1994;330:1029-1035.
7. Yaffe K, Clemons TE, McBee WL, Lindblad AS; Age-Related Eye Disease Study Research Group. Impact of antioxidants, zinc, and copper on cognition in the elderly: a randomized, controlled trial. Neurology. 2004;63(9):1705-1707.
8. Clemons TE, Kurinij N, Sperduto RD; AREDS Research Group. Associations of mortality with ocular disorders and an intervention of high-dose antioxidants and zinc in the Age-Related Eye Disease Study: AREDS Report No. 13. Arch Ophthalmol. 2004;122(5):716-726.
9. Davis MD, Gangnon RE, Lee LY, et al; Age-Related Eye Disease Study Research Group. The Age-Related Eye Disease Study severity scale for age-related macular degeneration: AREDS Report No. 17. Arch Ophthalmol. 2005;123(11):1484-1498.
10. Ferris FL, Davis MD, Clemons TE, et al; The Age-Related Eye Disease Study (AREDS) Research Group. A simplified severity scale for age-related macular degeneration: AREDS Report No. 18. Arch Ophthalmol. 2005;123(11):1570- 1574.
11. Bressler NM, Bressler SB, Congdon NG, et al; Age-Related Eye Disease Study Group. Potential public health impact of Age-Related Eye Disease Study Results: AREDS Report No. 11. Arch Ophthalmol. 2003;121(11):1621-1624.